1. 90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years. (14th March 2016) Authors: Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi Journal: Cancer medicine Issue: Volume 5:Number 6(2016:Jun.) Page Start: 1093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL). Issue 10 (2nd October 2016) Authors: Balzarotti, Monica; Brusamolino, Ercole; Angelucci, Emanuele; Carella, Angelo Michele; Vitolo, Umberto; Russo, Eleonora; Congiu, Angelagiovanna; Gotti, Manuel; Massidda, Stefania; Botto, Barbara; Annechini, Giorgia; Spina, Michele; Re, Alessandro; Zilioli, Vittorio Ruggero; Merli, Francesco; Salv... Journal: Leukemia & lymphoma Issue: Volume 57:Issue 10(2016:Oct.) Page Start: 2375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Current and future therapeutic approaches for the treatment of follicular lymphoma. Issue 9 (2nd September 2018) Authors: Pulsoni, Alessandro; Cappelli, Luca Vincenzo; Ballotta, Laura; Canichella, Martina; Serrao, Alessandra; Annechini, Giorgia; D'Elia, Gianna Maria; Foà, Robin Journal: Expert review of anticancer therapy Issue: Volume 18:Issue 9(2018) Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy. (5th August 2019) Authors: Pulsoni, Alessandro; Della Starza, Irene; Cappelli, Luca V.; Tosti, Maria E.; Annechini, Giorgia; Cavalli, Marzia; De Novi, Lucia A.; D'Elia, Gianna M.; Grapulin, Lavinia; Guarini, Anna; Del Giudice, Ilaria; Foà, Robin Journal: British journal of haematology Issue: Volume 188:Number 2(2020) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Reappraising the timing of transplant for indolent non-Hodgkin lymphomas. Issue 10 (2nd October 2016) Authors: Capria, Saveria; Barberi, Walter; Perrone, Salvatore; Ferretti, Antonietta; Salaroli, Adriano; Annechini, Giorgia; D'Elia, Gianna Maria; Foà, Robin; Pulsoni, Alessandro Journal: Expert review of hematology Issue: Volume 9:Issue 10(2016) Page Start: 951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reduced Klebsiella pneumoniae carbapenemase–producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic. (11th December 2022) Authors: Laganà, Alessandro; Ferri, Gianluca; Passucci, Mauro; Salvatori, Martina; Bisegna, Maria Laura; Paoletti, Francesca; Aji, Francesco; Breccia, Massimo; Brunetti, Gregorio Antonio; Morano, Giacomo Salvatore; Annechini, Giorgia; Carmosino, Ida; Martelli, Maurizio; Girmenia, Corrado Journal: Infection control and hospital epidemiology Issue: Volume 43:Number 12(2022) Page Start: 1963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study. Issue 12 (December 2015) Authors: De Angelis, Federico; Tosti, Maria Elena; Capria, Saveria; Russo, Eleonora; D'Elia, Gianna Maria; Annechini, Giorgia; Stefanizzi, Caterina; Foà, Robin; Pulsoni, Alessandro Journal: Leukemia research Issue: Volume 39:Issue 12(2015:Dec.) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. Issue 4 (4th April 2023) Authors: Gotti, Manuel; Sciarra, Roberta; Pulsoni, Alessandro; Merli, Francesco; Luminari, Stefano; Zerbi, Caterina; Trentin, Livio; Re, Alessandro; Rusconi, Chiara; Viviani, Simonetta; Rossi, Andrea; Cocito, Federica; Botto, Barbara; Meli, Erika; Pinto, Antonello; Dogliotti, Irene; Gini, Guido; Puccini, ... Journal: HemaSphere Issue: Volume 7:Issue 4(2023) Page Start: e837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era. (May 2016) Authors: Perrone, Salvatore; D'Elia, Gianna Maria; Annechini, Giorgia; Ferretti, Antonietta; Tosti, Maria Elena; Foà, Robin; Pulsoni, Alessandro Journal: Leukemia research Issue: Volume 44(2016:May) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The current role of interferon in hairy cell leukaemia: clinical and molecular aspects. (1st May 2021) Authors: Assanto, Giovanni M.; Riemma, Costantino; Malaspina, Francesco; Perrone, Salvatore; De Luca, Maria L.; Pucciarini, Alessandra; Annechini, Giorgia; D'Elia, Gianna M.; Martelli, Maurizio; Foà, Robin; Tiacci, Enrico; Pulsoni, Alessandro Journal: British journal of haematology Issue: Volume 194:Number 1(2021) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗